MedCana Subsidiary in Colombia Enters Negotiations with Australian Firm for Pharma Cannabis Supply
MedCana (OTC: SFWJ), a global infrastructure holding company in the pharmaceutical-grade cannabis industry, has announced that one of its Colombian subsidiaries is in negotiations with an Australian pharmaceutical firm for a medical-grade cannabis supply agreement. The deal is expected to generate $100,000 to $200,000 in monthly revenue, potentially reaching $1.2 to $2.4 million annually.
CEO Jose Gabriel Diaz described this as a pivotal moment for MedCana's global expansion to meet the growing demand for pharmaceutical-grade cannabis. MedCana, formerly known as Software Effective Solutions, is focused on developing companies in the agricultural technology and cannabis industries.
MedCana (OTC: SFWJ), una holding globale nel settore della cannabis di grado farmaceutico, ha annunciato che una delle sue filiali in Colombia è in trattative con un'azienda farmaceutica australiana per un accordo di fornitura di cannabis di grado medico. Si prevede che l'accordo genererà $100.000 a $200.000 di entrate mensili, con un potenziale annuale di $1,2 a $2,4 milioni.
Il CEO Jose Gabriel Diaz ha descritto questo come un momento cruciale per l'espansione globale di MedCana per soddisfare la crescente domanda di cannabis di grado farmaceutico. MedCana, precedentemente nota come Software Effective Solutions, è concentrata nello sviluppo di aziende nei settori della tecnologia agricola e della cannabis.
MedCana (OTC: SFWJ), una empresa holding global en la industria del cannabis de grado farmacéutico, ha anunciado que una de sus filiales colombianas está en negociaciones con una firma farmacéutica australiana para un acuerdo de suministro de cannabis de grado médico. Se espera que el acuerdo genere $100,000 a $200,000 en ingresos mensuales, alcanzando potencialmente $1.2 a $2.4 millones anuales.
El CEO Jose Gabriel Diaz describió esto como un momento clave para la expansión global de MedCana para satisfacer la creciente demanda de cannabis de grado farmacéutico. MedCana, anteriormente conocida como Software Effective Solutions, se enfoca en desarrollar empresas en las industrias de tecnología agrícola y cannabis.
MedCana(OTC: SFWJ)는 제약 등급 대마초 산업의 글로벌 인프라 홀딩 회사이며, 콜롬비아 자회사가 호주 제약 회사와 의약용 대마초 공급 계약을 위해 협상 중이라고 발표했습니다. 이번 거래는 월 100,000달러에서 200,000달러의 수익을 발생시킬 것으로 예상되며, 잠재적으로 연간 120만 달러에서 240만 달러에 이를 것으로 보입니다.
CEO인 Jose Gabriel Diaz는 이를 MedCana의 글로벌 확장을 위한 중대한 순간으로 설명하며, 제약 등급 대마초에 대한 증가하는 수요를 충족할 것이라고 말했습니다. MedCana는 이전에 Software Effective Solutions로 알려졌으며, 농업 기술 및 대마초 산업에서 기업을 개발하는 데 집중하고 있습니다.
MedCana (OTC: SFWJ), une société holding globale dans l'industrie du cannabis de qualité pharmaceutique, a annoncé qu'une de ses filiales colombiennes est en négociations avec une entreprise pharmaceutique australienne pour un accord de fourniture de cannabis de qualité médicale. On s'attend à ce que cet accord génère entre 100 000 et 200 000 dollars de revenus mensuels, atteignant potentiellement entre 1,2 et 2,4 millions de dollars par an.
Le PDG Jose Gabriel Diaz a décrit cela comme un moment décisif pour l'expansion mondiale de MedCana afin de répondre à la demande croissante pour du cannabis de qualité pharmaceutique. MedCana, anciennement connue sous le nom de Software Effective Solutions, se concentre sur le développement d'entreprises dans les secteurs de la technologie agricole et du cannabis.
MedCana (OTC: SFWJ), ein globales Infrastruktur-Holdingunternehmen in der Cannabis-Industrie für pharmazeutische Qualität, hat angekündigt, dass eine seiner kolumbianischen Tochtergesellschaften in Verhandlungen mit einem australischen Pharmaunternehmen über eine Liefervereinbarung für medizinisches Cannabis steht. Der Deal wird voraussichtlich monatliche Einnahmen von 100.000 bis 200.000 US-Dollar generieren, die potenziell jährlich 1,2 bis 2,4 Millionen US-Dollar erreichen könnte.
CEO Jose Gabriel Diaz beschrieb dies als wendenden Moment für die globale Expansion von MedCana, um der wachsenden Nachfrage nach pharmazeutischem Cannabis gerecht zu werden. MedCana, früher bekannt als Software Effective Solutions, konzentriert sich auf die Entwicklung von Unternehmen in den Bereichen Agrartechnologie und Cannabis.
- Potential annual revenue of $1.2 to $2.4 million from the new supply agreement
- Expansion into the Australian pharmaceutical cannabis market
- Demonstrates MedCana's ability to secure international contracts
- Agreement still in negotiation phase, not finalized
- Exact revenue figures are projections, not guaranteed
MedCana to enter into supply Agreement worth
The agreement is projected to provide between
Jose Gabriel Diaz, CEO of MedCana, stated, "This agreement represents a pivotal moment for MedCana as we continue expanding globally to meet the increasing demand for pharmaceutical-grade cannabis."
About SFWJ/Medcana
Software Effective Solutions/MedCana is a holding company focused on developing companies in the agricultural technology and cannabis industries. As MedCana moves forward with its expansion plans, the company remains committed to delivering on its promise of building a solid foundation for the future growth of its holdings.
For more information, please visit: www.MedCana.net
Or connect with us via:
MedCana | LinkedIn
https://X.com/@MedcanaCo
SAFE HARBOR STATEMENT
This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
View original content:https://www.prnewswire.com/news-releases/medcana-subsidiary-in-colombia-enters-negotiations-with-australian-firm-for-pharma-cannabis-supply-302277352.html
SOURCE MedCana
FAQ
What is the potential annual revenue for MedCana (SFWJ) from the new Australian supply agreement?
Which subsidiary of MedCana (SFWJ) is negotiating the cannabis supply agreement?
What type of cannabis product will MedCana (SFWJ) supply to the Australian firm?
When did MedCana (SFWJ) announce the negotiations for the Australian supply agreement?
